AUTHOR=Zhang Xinmiao , Shen Jinhai , Huang Mengfan , Li Rongxia 

TITLE=Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials

JOURNAL=Frontiers in Immunology

VOLUME=15

YEAR=2024

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1507977

DOI=10.3389/fimmu.2024.1507977

ISSN=1664-3224